SCHEMBL7363060

SCHEMBL7363060

CNC(=O)C(=O)CCCCCCC(=O)NNC(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.70
HDAC1 Q13547 12/20 0.67
HDAC2 Q92769 12/20 0.67
HDAC3 O15379 5/20 0.60
HDAC4 P56524 5/20 0.60
HDAC7 Q8WUI4 5/20 0.60
HDAC10 Q969S8 5/20 0.60
HDAC11 Q96DB2 5/20 0.60
HDAC8 Q9BY41 5/20 0.60
HDAC6 Q9UBN7 5/20 0.60
HDAC9 Q9UKV0 5/20 0.60
HDAC5 Q9UQL6 5/20 0.60
TDP1 Q9NUW8 1/20 0.54
CTDSP1 Q9GZU7 2/20 0.53
NPC1 O15118 1/20 0.53
RAB9A P51151 1/20 0.53
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
LMNA P02545 1/20 0.50
KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7365346 0.92 HDAC1 (0.63) POLBHDAC1HDAC2HDAC3HDAC4
SCHEMBL7368674 0.83 HDAC1 (0.80) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL12768686 0.79 POLB (0.67) POLBHDAC1HDAC2HDAC3HDAC4
SCHEMBL12768681 0.79 POLB (0.67) POLBHDAC1HDAC2HDAC3HDAC4
SCHEMBL12768688 0.79 POLB (0.67) POLBHDAC1HDAC2HDAC3HDAC4
SCHEMBL12323197 0.77 POLB (0.69) POLBHDAC1HDAC2HDAC3HDAC4
SCHEMBL6637333 0.75 POLB (0.81) POLBTDP1ALDH1A1GAALMNA
SCHEMBL7364498 0.75 HDAC1 (1.00) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL24653245 0.75 HDAC1 (0.78) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL7363461 0.74 ALDH1A1 (0.59) HDAC1HDAC2HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 POLB 418/4885HDAC1 1/4885HDAC2 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.